Raymond James & Associates Revolution Medicines, Inc. Transaction History
Raymond James & Associates
- $161 Billion
- Q3 2024
A detailed history of Raymond James & Associates transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Raymond James & Associates holds 190,505 shares of RVMD stock, worth $10.8 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
190,505
Previous 74,370
156.16%
Holding current value
$10.8 Million
Previous $2.89 Million
199.06%
% of portfolio
0.01%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding RVMD
# of Institutions
266Shares Held
161MCall Options Held
260KPut Options Held
620K-
Vanguard Group Inc Valley Forge, PA14.9MShares$842 Million0.01% of portfolio
-
Black Rock Inc. New York, NY13.4MShares$757 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA11.4MShares$644 Million0.09% of portfolio
-
Farallon Capital Management LLC San Francisco, CA11.3MShares$639 Million2.58% of portfolio
-
Baker Bros. Advisors LP New York, NY7.57MShares$427 Million3.67% of portfolio
About Revolution Medicines, Inc.
- Ticker RVMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,697,600
- Market Cap $4.95B
- Description
- Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...